Table 1. Characteristics of mice fed HFD, HFD with rosuvastatin, and HFD with pitavastatin.
HFD | HFD + Rosuvastatin | HFD + Pitavastatin | p value | |
---|---|---|---|---|
(n = 6) | (n = 10) | (n = 10) | ||
Baseline (8 weeks) | ||||
Body weight | 25.7 ± 1.8 | 23.4 ± 1.4* | 24.2 ± 1.7 | 0.028 |
At the end of treatment (20 weeks) | ||||
Body weight (g) | 39.2 ± 6.5 | 34.8 ± 4.6 | 34.2 ± 3.0 | 0.110 |
Weight gain (g) | 13.4 ± 5.1 | 11.4 ± 4.3 | 10.0 ± 3.6 | 0.323 |
Liver (g) | 1.4 ± 0.3 | 1.3 ± 0.3 | 1.2 ± 0.2 | 0.433 |
Epididymal fat (g) | 2.0 ± 0.5 | 1.7 ± 0.8 | 1.7 ± 0.5 | 0.670 |
Data are expressed as the mean ± SD and compared by one-way ANOVA, Dunnett's post-test.
p < 0.05 versus HFD group. HFD; high fat diet.